What is Palvella Therapeutics's operating lease ROU assets?

Palvella Therapeutics (PVLA) reported operating lease ROU assets of $528K in Q1 2026.

What is the long-term trend for Palvella Therapeutics's operating lease ROU assets?

Over 4 years (2020 to 2025), Palvella Therapeutics's operating lease ROU assets has grown at a -38.2% compound annual growth rate (CAGR), from $3.93M to $572K.

What does operating lease ROU assets mean?

Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Palvella Therapeutics PVLA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Relay Therapeutics, Inc.RLAY

$38.59M-23.0%

Viridian Therapeutics, Inc.VRDN

$2.26M+2,424,731,083%

PrecigenPGEN

11.4%-0.1pp

Arcutis Biotherapeutics, Inc.ARQT

$4.36M+137%

Kodiak Sciences IncKOD

$34.38M-19.1%

LQD

Liquidia CorporationLQDA

$4.36M+5.5%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's operating lease ROU assets?: Palvella Therapeutics (PVLA) reported operating lease ROU assets of $528K in Q1 2026.
What is the long-term trend for Palvella Therapeutics's operating lease ROU assets?: Over 4 years (2020 to 2025), Palvella Therapeutics's operating lease ROU assets has grown at a -38.2% compound annual growth rate (CAGR), from $3.93M to $572K.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.